US EditionPrivacy Concerns: 23andMe Restructures as Nonprofit with Acquisition by TTAM Research Institute - USA Herald
Summary by USA Herald
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Privacy Concerns: 23andMe Restructures as Nonprofit with Acquisition by TTAM Research Institute - USA Herald
The sale of 23andMe has been finalized, transforming the once-public genetics company into a nonprofit under the leadership of its cofounder, Anne Wojcicki. The deal—approved by U.S. Bankruptcy Judge Brian C. Walsh—marks the end of a months-long bidding war following 23andMe’s bankruptcy filing in March 2025. TTAM Outbids Regeneron in $305 Million Deal Biotech firm Regeneron Pharmaceuticals had previously bid $265 million to acquire the company…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
